Full Press Release Details
Unassociated Document
| Contact : | Fresenius Medical Care AG & Co. KGaA | ||
| Oliver Maier | Else-Kr ner-Str.1 | ||
| Phone: | + 49 6172 609 2601 | 61352 Bad Homburg | |
| Fax: | + 49 6172 609 2301 | Germany | |
| www.fmc-ag.com | |||
| North America: | |||
| Terry L. Morris | |||
| Phone: | + 1 800 948 2538 | ||
| Fax: | + 1 615 345 5605 | ||
| E-mail: | ir@fmc-ag.com | February 24, 2011 |
Fresenius Medical Care Publishes Form 20-F
for the Fiscal Year 2010
Germany - Fresenius Medical Care AG & Co. KGaA ("the company" or "Fresenius Medical Care"),
the world's largest provider of dialysis products and services, today announced that it has filed the annual report
2010 under Form 20-F with the U.S. Securities and Exchange Commission (SEC). The report is available
at the company's website www.fmc-ag.com in the "Investor Relations" section as well as at the SEC's website,
hard copy of Fresenius Medical Care's annual report on Form 20-F including the
complete audited financial statements may be obtained from the company free of charge upon request
to the company's Investor Relations department by email at ir@fmc-ag.com.
Fresenius Medical Care
Medical Care is the world's largest integrated provider of products and services for individuals undergoing dialysis because of
chronic kidney failure, a condition that affects more than 1.89 million individuals worldwide. Through its network of 2,757 dialysis
clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to
214,648 patients around the globe. Fresenius Medical Care also is the world's leading provider of dialysis products such as hemodialysis
machines, dialyzers and related disposable products.
release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially
from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive
conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings,
and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co.
KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake
any responsibility to update the forward-looking statements in this release.